Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Trastuzumab Cardiotoxicity”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableUnknownNCT04961307
What this trial is testing

Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab

Who this might be right for
CardiotoxicityAntitumor DrugsBreast Cancer+1 more
Peking University Third Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01436604
What this trial is testing

Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging

Who this might be right for
Cancer, BreastLV Dysfunction
Centre Francois Baclesse 19
Not applicableEnrolling By InvitationNCT01173341
What this trial is testing

Cardiotoxicity of Cancer Therapy (CCT)

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 700
Post-approval studies (Phase 4)Study completedNCT02696707
What this trial is testing

An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 200
Not applicableLooking for participantsNCT02772367
What this trial is testing

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 120
Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Early research (Phase 1)Study completedNCT04023110
What this trial is testing

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Who this might be right for
CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more
Abramson Cancer Center at Penn Medicine 68
Not applicableLooking for participantsNCT07426913
What this trial is testing

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Who this might be right for
Breast CancerAnthracycline Related Cardiotoxicity in Breast CancerVirtual Reality+1 more
Virginia Commonwealth University 30
Testing effectiveness (Phase 2)UnknownNCT01016886
What this trial is testing

Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research

Who this might be right for
Breast CancerHeart Failure
University of Alberta 99
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Testing effectiveness (Phase 2)Ended earlyNCT00377780
What this trial is testing

Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
Laurence J.C. van Warmerdam 60
Not applicableStudy completedNCT01665300
What this trial is testing

Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity

Who this might be right for
Left Ventricular Function Systolic DysfunctionCardiotoxicity
Seoul National University Hospital 120
Large-scale testing (Phase 3)UnknownNCT02236806
What this trial is testing

Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab

Who this might be right for
Breast CancerCardiotoxicity
Azienda Ospedaliero-Universitaria Careggi 262
Not applicableUnknownNCT04429633
What this trial is testing

Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer

Who this might be right for
CardiotoxicityBreast CancerPrevention+2 more
Samsung Medical Center 136
Testing effectiveness (Phase 2)Study completedNCT01009918
What this trial is testing

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Who this might be right for
Breast CancerCardiac Toxicity
University of South Florida 468
Not applicableStudy completedNCT00875238
What this trial is testing

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

Who this might be right for
Breast CancerCardiac ToxicityCardiovascular Complications
Vanderbilt University 133
Not applicableStudy completedNCT02615054
What this trial is testing

Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors

Who this might be right for
Trastuzumab CardiotoxicityHER2-Positive Breast Cancer Survivors
Memorial Sloan Kettering Cancer Center 58
Not applicableStudy completedNCT00858039
What this trial is testing

Cardiotoxicity of Adjuvant Trastuzumab

Who this might be right for
Breast NeoplasmsHeart Failure
Royal Prince Alfred Hospital, Sydney, Australia 220
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Not applicableActive Not RecruitingNCT05078190
What this trial is testing

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer

Who this might be right for
Breast CancerCardiotoxicityDrug-Related Side Effects and Adverse Reactions+1 more
Abramson Cancer Center at Penn Medicine 200
Next Page